[研究报告] 血浆分馏市场预计将从 2021 年的 265.7583 亿美元增长至 2028 年的 407.3198 亿美元;预计 2021-2028 年血浆分馏市场复合年增长率为 6.3%。
分析师观点
由于血浆疗法在治疗新型疾病方面的应用日益增多,以及血浆在设计治疗产品中的应用日益增多,全球血浆分离市场预计将增长。此外,在 COVID-19 大流行期间,血浆疗法的需求激增,这推动了血浆分离市场的增长。此外,自身免疫性疾病、传染病和免疫性疾病的发病率不断上升,为市场增长提供了重要的增长机会。对血浆疗法优势的认识不断增强,增加了发达国家的血浆分离。与此同时,发展中国家正在努力提高其获取血浆的能力,扩大血浆疗法的使用范围。例如,根据印度政府的数据,该国有 2700 多个血库,每年收集近 1000-1100 万个血液单位。然而,统计数据显示,该国经常出现血浆短缺的情况,与发达国家相比,人均血浆衍生物的使用量较少。然而,发达国家对血浆分离的认识不断提高以及投资不断增加,为 2021-2028 年血浆分离市场的增长铺平了道路。
市场概况
分离血浆中各种成分的过程 称为血浆分馏。分离的成分用于制造各种治疗性血浆产品,可用于治疗各种疾病。免疫球蛋白、凝血因子、白蛋白和抑制剂只是常用的几种血浆产品。血浆分馏市场的增长主要受到以下因素的推动:血浆疗法的应用日益广泛,以及参与者公司积极参与推动市场增长的市场发展。然而,重组或非血浆产品的可用性阻碍了市场的增长。全球血浆分馏市场根据产品、应用和最终用户进行细分。根据地域,市场分为北美、欧洲、亚太、中东和非洲以及南美和中美。北美地区在血浆分馏市场中占有最大的市场份额,而亚太地区估计是增长最快的地区。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
市场驱动因素
血浆疗法的应用日益广泛
血浆是治疗各种慢性疾病的新兴方法之一。血浆由蛋白质、白蛋白、球蛋白、纤维蛋白原、凝血因子和抑制剂等基本成分组成。它广泛用于治疗血癌、COVID19、心房颤动、白血病等。血浆通过血浆分馏从捐献的血液中分离出来。监管机构也在为在治疗过程中使用血浆提供必要的批准。例如,2020 年 8 月,美国食品药品监督管理局 (USFDA) 发布了 COVID-19 恢复期血浆治疗的紧急使用授权 (EUA)。除此之外,2021 年 2 月,美国食品药品监督管理局发布了 COVID19 血浆 EUA 的最新指南。因此,监管机构和政府的积极参与和批准有望鼓励血浆的应用。血浆可以在献血后 24 小时内冷冻保存长达一年,以保护宝贵的凝血因子,并可在解冻后使用。世界各地的每个国家都设立了许多血库,可以接触到医疗服务提供者,并由各国政府和其他组织资助。例如,2021 年,美国血库协会 (AABB) 为“设计免疫疗法抗性造血以治疗高风险急性髓细胞白血病”等研究项目提供了资金(由 Pietro Genovese,理学学士、理学硕士、博士、儿科助理教授、基因治疗项目、Dana-Farber/波士顿儿童癌症和血液病中心、Dana-Farber 癌症研究所)、“研究和治疗输血引起的同种抗体介导疾病的新方法”(由 Simon J. Cleary 博士;加州大学医学-肺科博士后研究员)等。因此,根据上述因素,预测期内血浆分馏相关市场。
细分分析
全球血浆分馏市场根据产品、应用和最终用户进行细分。根据产品,市场细分为免疫球蛋白、白蛋白、凝血因子浓缩物、蛋白酶抑制剂等。免疫球蛋白 细分市场很可能在 2021 年占据最大的市场份额。此外,预计在 2021-2028 年期间,它将在市场上实现最高的复合年增长率。由于传染病的流行率不断上升,以及政府和监管机构在产品开发和审批方面的积极支持,预计该细分市场将在预测期内为市场做出巨大贡献。例如,2021 年 5 月,美国食品药品监督管理局 (FDA) 发布了一项紧急使用授权,授权在研单克隆抗体疗法“Sotrovimab”用于治疗成人和儿科患者的轻度至中度 COVID-19。此外,免疫球蛋白细分为静脉注射免疫球蛋白、皮下注射和其他。
根据应用,市场细分为神经病学、免疫学、血液学、重症监护、肺病学等。2021 年,神经病学领域占据了血浆分馏市场的最大市场份额。然而,由于全球各种医疗状况的检测和诊断增加,预计血液学领域将在 2021 年至 2028 年期间以最快的复合年增长率增长。
根据最终用户,市场分为医院和诊所、临床研究实验室和学术机构。2021 年,医院和诊所部门可能会占据最大的市场份额。此外,由于全球各种医疗状况的检测和诊断增加,预计临床研究实验室部门的需求也将在 2021 年至 2028 年期间以最快的复合年增长率增长。
区域分析
北美占据全球血浆分馏市场的最大市场份额,2021 年价值 94.8491 亿美元,预计 2021-2028 年的复合年增长率为 6.5%。北美血浆分馏市场分为美国、加拿大和墨西哥。该地区市场的增长被广泛归因于凝血因子浓缩物、凝血因子浓缩物和其他血浆衍生产品在治疗各种血液疾病(如血友病 A、血友病 B)中的应用日益增多。此外,由于多发性硬化症和其他神经系统疾病的患病率不断上升,预计加拿大市场的增长也将增长。此外,在墨西哥,由于人们对血液和相关疾病以及免疫疾病的认识不断提高,以及对血浆衍生疗法在治疗慢性疾病中的认识不断提高,预计市场也将增长。另一方面,预计亚太地区在 2021 年至 2028 年期间的复合年增长率最高。该地区市场的增长归因于国际参与者对中国和印度日益增长的兴趣、中国等国家的政府支持以及医疗保健基础设施的进步。因此,该地区在预测期内为血浆分离市场参与者提供了巨大的增长潜力。
关键球员分析
血浆分离市场主要由以下参与者组成:Bio Products Laboratory LTD、CSL Limited、Biotest AG、Sanquin、Bharat Serums and Vaccines Limited、Grifols SA、Kedrion、SK Plasma、Plasmagen Biosciences PVT. LTD、Octapharma AG 等。市场领先的两家参与者是 CSL Limited 和 Grifols SA。这两家公司参与了各种有机和无机开发,为巨大的增长机会铺平了道路。
血浆分离市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响血浆分馏市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的血浆分馏市场细分和地理位置。
- 获取血浆分馏市场的区域特定数据
血浆分馏市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 265.8亿美元 |
2028 年市场规模 | 407.3亿美元 |
全球复合年增长率(2021 - 2028) | 6.3% |
史料 | 2019-2020 |
预测期 | 2022-2028 |
涵盖的领域 | 按产品
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
市场参与者密度:了解其对商业动态的影响
血浆分馏市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在血浆分馏市场运营的主要公司有:
- 巴斯夫
- 泰米尔纳德邦
- 创新蛋白质组学
- 华大基因
- RTI国际
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 获取血浆分馏市场顶级关键参与者概述
最新动态
血浆分离市场中的公司高度采用无机和有机战略。以下列出了一些近期的关键市场发展:
- 2020 年 4 月,全球血浆衍生药物制造商 Grifols 宣布推出一种新的 3 毫升 HyperRAB 药瓶,用于治疗狂犬病的暴露后预防。美国食品药品管理局已于 2019 年批准了这种药瓶。
- 2021 年 5 月,Liminal BioSciences 与 Kedrion 达成协议,剥离其血浆收集和血浆衍生治疗业务。
- 2021 年 4 月,BPL 与 Atlantic Research Group 达成长期合作。该协议确立了 ARG 成为 BPL 首选合同研究组织 (CRO) 的地位,负责开展临床研究试验并为公司的全球新产品开发计划提供支持服务。该协议以 BPL 和 ARG 之前在临床试验计划方面的成功合作为基础。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Virtual Pipeline Systems Market
- Constipation Treatment Market
- Malaria Treatment Market
- MEMS Foundry Market
- Small Internal Combustion Engine Market
- Micro-Surgical Robot Market
- Real-Time Location Systems Market
- Architecture Software Market
- Saudi Arabia Drywall Panels Market
- Analog-to-Digital Converter Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global plasma fractionation market is being driven by factors such rising application of plasma therapy and active participation of the players in market developments, development potential in emerging countries are likely to offer significant opportunities for the growth of the global plasma fractionation market.
The Asia Pacific is expected to be the fastest-growing region in the plasma fractionation market. The growth of the market in this region is primarily due to the rising application of plasma therapy and the active participation of the players in market developments
The process of separating various components of blood plasma is known as plasma fractionation. The separated components are used to create a variety of therapeutic plasma products that can be used to treat a variety of medical conditions. Immunoglobulin, coagulation factors, albumins, and inhibitors are just a few of the plasma products commonly used.
The availability of non-plasma products is the significant factor that will hinder the plasma fractionation market growth.
The market players in the global market in constantly involved in the product development and innovations as part of their business strategies such as product launch, mergers and acquisitions, partnership and others. For instance, in July 2020, Grifols has entered into purchase agreements with South Korean-based GC Pharma (Group) through which the company would buy a plasma fractionation plant and two purification facilities in Montreal and 11 plasma collection locations in the United States, a total of US$460 million.
The key players in the global plasma fractionation are Bio Products Laboratory LTD, CSL Limited, Biotest AG, Sanquin, Bharat Serums and Vaccines Limited, Grifols S.A, Kedrion, SK Plasma, Plasmagen Biosciences PVT. LTD, Octapharma AG and among others.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Plasma Fractionation Market
- BASF SE
- TMIC
- Creative Proteomics
- BGI
- RTI International
- Afekta Technologies Ltd.
- Fred Hutchinson Cancer Research Center
- West Coast Metabolomics Center
- Molecular You
- Metabolon, Inc.
- biocrates life sciences ag
- Chenomx Inc.
- C-CAMP
- metaSysX
- MS-Omics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.